T. Muley et al., ELASTINOLYTIC ACTIVITY OF ALVEOLAR MACROPHAGES IN SMOKING-ASSOCIATED PULMONARY-EMPHYSEMA, The Clinical investigator, 72(4), 1994, pp. 269-276
Current concepts of pathomechanisms leading to acquired emphysema sugg
est that alveolar macrophages (AM) activated by cigarette smoking may
cause an elastase/antielastase imbalance localized to the microenviron
ment formed by phagocytes and lung tissue. A functional cell assay was
used to evaluate the cell-associated elastinolytic activity of AM. AM
were obtained by bronchoalveolar lavage from patients with emphysema
and from patients with non obstructive chronic pulmonary diseases (non
-COPD) and cultured under serum-free conditions in direct contact with
H-3-labeled elastin particles. Elastinolytic activity was calculated
from the released radioactivity in culture supernatants and expressed
as micrograms of H-3-elastin degraded x 10(-5) AM x 72 h-1. AM of pati
ents with emphysema had significantly higher elastinolytic activity co
mpared to that of non-COPD patients (median: 10.8 versus 4.1 mug; P <
0.01). Further differentiation of patients revealed the lowest median
activity in sarcoidosis (2.3 mug). In respect to smoking habits there
was a major difference between smokers with and those without emphysem
a; AM of smokers with emphysema degraded more than twice the amount of
elastin than smokers in the non-COPD group (median:11 versus 3.9 mug,
P = 0.01). From these data we conclude that AM-derived elastinolytic
proteases may be involved in the destruction of lung elastin, which is
thought to be the key event occurring in the pathogenesis of pulmonar
y emphysema.